연구성과로 돌아가기

2021 연구성과별 연구자 정보 (1148 / 2991)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Sohn, Joo Hyun Sohn, JH 13 Hanyang Univ, Coll Med, Hanyang Univ Hosp, Dept Internal Med, Seoul, South Korea
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Lee, Jun-Hyuk Lee, JH 14 Eulji Med Ctr, Daejeon, South Korea
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Shim, Jae-Jun Shim, JJ 15 Kyunghee Univ Hosp, Dept Internal Med, Seoul, South Korea
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Jeong, Soung Won Jeong, SW 16 Soonchunhyang Univ, Coll Med, Dept Internal Med, Asan, South Korea
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Cho, Yong Kyun Cho, YK 17 Sungkyunkwan Univ, Sch Med, Dept Internal Med, Seoul, South Korea
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Kim, Hyoung Su Kim, HS 18 Hallym Univ, Med Ctr, Kangdong Sacred Heart Hosp, Internal Med, Seoul, South Korea HQZ-0240-2023 Kim, Yong-Tae
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Nam, Joon Yeul Nam, JY 19 Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Nam, Joon Yeul Nam, JY 19 Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Lee, Yun Bin Lee, YB 20 Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea AAB-9799-2022 Lee, Yoojin
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Lee, Yun Bin Lee, YB 20 Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea AAB-9799-2022 Lee, Yoojin
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Kim, Yoon Jun Kim, YJ 21 Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Kim, Yoon Jun Kim, YJ 21 Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Yoon, Jung-Hwan Yoon, JH 22 Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea J-5563-2012 Yoon, Jung
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Yoon, Jung-Hwan Yoon, JH 22 Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea J-5563-2012 Yoon, Jung
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Zoulim, Fabien Zoulim, F 23 Hosp Civils Lyon, Croix Rousse Hosp, Dept Virol, Lyon, France
페이지 이동: